The FDA has approved Valtoco (diazepam nasal spray; Neurelis) for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity that are distinct from a patient’s usual seizure pattern in patients with epilepsy 6 years of age and older.
Researchers established a prediction model based on the additive effect of 4 independent factors that form an accurate model for predicting the risk of drug-resistant epilepsy in children with cerebral palsy.
This study described data collected from patients who self-selected to participate in the Cleveland Clinic Epilepsy Center’s virtual follow-up program.
Children with pediatric epilepsy who undergo surgery may experience long-term changes in verbal and nonverbal IQ.
Patients with sepsis, particularly younger patients and those with CKD, may be at an elevated risk for new-onset epilepsy.
Compared to nonhormonal contraception, hormonal contraception appears to pose a greater risk for increased seizure frequency in women with epilepsy.
Using artificial tools to collect and analyze conversations and comments about epilepsy posted online, researchers revealed that 7.8% of all posts by teenagers with epilepsy were related to suicide, compared with 3.2% of adult posts.
Poor seizure control, lack of breastfeeding education from a neurologist or lactation consultant, are factors contributing to lower breastfeeding rates in women with epilepsy, compared with the general population.
Investigators report cardiac arrhythmias with or without apnea among patients with epilepsy are associated with increased mortality risk.
Researchers found hypertension is associated with a 2.5-fold increased risk for developing epilepsy in older age, a risk that may be mitigated by hypertension treatment.
